New study shows that the odds of suffering severe post-operative pain are six times lower with NOL
New study reveals promising findings regarding the ability of Medasense’s NOL monitor to reduce postoperative pain.
New study confirms that postoperative pain can be reduced with NOL guided analgesia
New study reveals promising findings regarding the ability of Medasense’s NOL monitor to reduce postoperative pain.
Study Explores the Ability of NOL Technology to Detect Pain in the ICU
New study reveals promising findings regarding the ability of Medasense’s NOL monitor to detect pain response levels in ICU patients.
Pain Monitoring Helps Assess the Effectiveness of Opioid-Sparing Approaches during Surgery
New study shows that effective opioid-sparing anaesthesia with dexmedetomidine can be guided with NOL pain monitoring technology.
Pain Monitoring Technology (NOL) is Shown to Reduce Postoperative Pain and Health Costs
Press release: Monitoring pain response levels during surgery with NOL technology can help reduce postoperative pain as well as healthcare costs.
NOL Pain Response Monitoring Secures Marketing Approval in Brazil
NOL pain response monitoring has been approved for marketing in Brazil.
New Study: NOL Monitoring Can Help Reduce Postoperative Pain
A new study has found that monitoring pain response levels during surgery with NOL technology can help reduce postoperative pain.
Medasense Raises $18M in Series C Round
Medasense raises $18M in Series C round
Economic Study Shows Cost Benefits of NOL Technology
A new economic study has shown that NOL technology is likely to help reduce the cost of care for hospitals.
EU Prize for Women Innovators
Medasense Founder and CEO Galit Zuckerman-Stark has been named one of 13 finalists for the EU Prize for Women Innovators 2020.
- 1
- 2
- 3
- 4
- 5
- Go to the next page
